FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 265

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CAI Nasdaq Caris Life Sciences, Inc. 2830
CATX NYSE American Perspective Therapeutics, Inc. 2830
CBIO Nasdaq Crescent Biopharma, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CELZ Nasdaq Creative Medical Technology Holdings, In 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGTX Nasdaq Cognition Therapeutics, Inc. 2830
CLDX Nasdaq Celldex Therapeutics, Inc. 2830
CLX New York The Clorox Company 2830
CLYM Nasdaq Climb Bio, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNSP Nasdaq CNS Pharmaceuticals, Inc. 2830
COGT Nasdaq Cogent Biosciences, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPRX Nasdaq Catalyst Pharmaceuticals, Inc. 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CRVS Nasdaq Corvus Pharmaceuticals, Inc. 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CUE Nasdaq Cue Biopharma, Inc. 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2830
DTIL Nasdaq Precision BioSciences, Inc. 2830
DWTX Nasdaq Dogwood Therapeutics, Inc. 2830
EIKN Nasdaq Eikon Therapeutics, Inc. 2830
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2830
ELTX Nasdaq Elicio Therapeutics, Inc. 2830
ELVN Nasdaq Enliven Therapeutics, Inc. 2830
ENLV Nasdaq Enlivex Ltd. 2830
ENSC Nasdaq Ensysce Biosciences, Inc. 2830
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2830
EOLS Nasdaq Evolus, Inc. 2830
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EYPT Nasdaq EyePoint, Inc. 2830
FHTX Nasdaq Foghorn Therapeutics Inc. 2830
GALDY Over the counter Galderma Group AG 2830
GALT Nasdaq Galectin Therapeutics Inc. 2830
GDTC Nasdaq CytoMed Therapeutics Limited 2830
GLMD Nasdaq Galmed Pharmaceuticals Ltd. 2830
GLPG Nasdaq Galapagos NV 2830
GMAB Nasdaq Genmab A/S 2830
GNFTY Over the counter Genfit S.A. 2830
GNLX Nasdaq Genelux Corporation 2830
GNTA Nasdaq Genenta Science S.p.A. 2830
Results 50 through 100 of 265